Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Buccal formulation of avanafil with enhanced bioavailability and prolonged duration

Buccal formulation of avanafil with enhanced bioavailability and prolonged duration

US Patent 11648205 · Granted May 16, 2023

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Buccal formulation of avanafil with enhanced bioavailability and prolonged durat2024
Buccal formulation of avanafil with enhanced bioavailability and prolonged durat2024
Buccal formulation of avanafil with enhanced bioavailability and prolonged durat2024
Buccal formulation of avanafil with enhanced bioavailability and prolonged durat2024
Buccal formulation of avanafil with enhanced bioavailability and prolonged durat2024
Methods for treating metabolic disorder2022
Methods for treating metabolic disorder2022
Ketoconazole ophthalmic preparations containing trans-ethosomal drug nanoparticl2022
Self-nanoemulsifying 3D-printed tablet composition and method of use thereof2022
Self-nanoemulsifying 3D-printed tablet composition and method of use thereof2022
Transfersome-containing transdermal film formulations and methods of use2021
Transfersome-containing transdermal film formulations and methods of use2021